Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · November 02, 2022

Efficacy of a Drug-Eluting Stent vs Bare-Metal Stent for Symptomatic Femoropopliteal Peripheral Artery Disease



Additional Info

Disclosure statements are available on the authors' profiles:

Efficacy of a Drug-Eluting Stent Versus Bare Metal Stents for Symptomatic Femoropopliteal Peripheral Artery Disease: Primary Results of the EMINENT Randomized Trial
Circulation 2022 Oct 18;[EPub Ahead of Print], Y Gouëffic, G Torsello, T Zeller, G Esposito, F Vermassen, KA Hausegger, G Tepe, M Thieme, M Gschwandtner, A Kahlberg, M Schindewolf, M Sapoval, J Diaz-Cartelle, K Stavroulakis

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading